Safety of dupilumab in severe atopic dermatitis and infection of Covid‐19: two case reports

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-07, Vol.34 (7), p.e303-e304
Hauptverfasser:	Ferrucci, S., Romagnuolo, M., Angileri, L., Berti, E., Tavecchio, S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Betacoronavirus - isolation & purification Coronavirus Infections - complications Coronavirus Infections - virology COVID-19 Covid‐19 Special Forum Dermatitis, Atopic - complications Dermatitis, Atopic - drug therapy Dermatology Female Humans Interleukin-4 Receptor alpha Subunit - immunology Letter To The Editor Life Sciences & Biomedicine Male Middle Aged Pandemics Pneumonia, Viral - complications Pneumonia, Viral - virology SARS-CoV-2 Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!